Karyopharm Therapeutics Inc
(NASDAQ:KPTI)
$1.25
-0.035[-2.72%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$1.25
0[0.00%]
Open1.270Close1.250
Vol / Avg.554.717K / 2.252MMkt Cap142.943M
Day Range1.215 - 1.28052 Wk Range1.110 - 6.010

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Karyopharm Therapeutics Stock (NASDAQ:KPTI) Earnings Dates and Earning Calls

Karyopharm Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 2

EPS Estimate

$-0.280

Quarterly Revenue Estimate

$37.4M

Annual Revenue (as of Jun 30)

$146M

Earnings History

Analyze the earnings history of Karyopharm Therapeutics using advanced sorting and filters.

Q

When is Karyopharm Therapeutics (NASDAQ:KPTI) reporting earnings?

A

Karyopharm Therapeutics (KPTI) is scheduled to report earnings on November 2, 2023. The last reported earnings were for reported on August 2, 2023 for Q2.

Q

What were the latest earnings per share (EPS) for Karyopharm Therapeutics (NASDAQ:KPTI)?

A

The Actual EPS was $-0.29, which beat the estimate of $-0.34.

Q

What were Karyopharm Therapeutics’s (NASDAQ:KPTI) revenues?

A

The Actual Revenue was $37.6M, which beat the estimate of $36.2M.

Browse earnings estimates, EPS, and revenue on all stocks.

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2023 Benzinga | All Rights Reserved